Limited Offer
Pediatric Dermatology Part II, An Issue of Dermatologic Clinics
- 1st Edition, Volume 40-2 - April 6, 2022
- Editor: Kelly M. Cordoro
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 8 9 7 6 2 - 4
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 9 7 6 3 - 1
In this issue of Dermatologic Clinics, guest editor Dr. Kelly M. Cordoro brings her considerable expertise to the topic of Pediatric Dermatology. Top experts in the field cover… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote-
Contains 11 relevant, practice-oriented topics including clinical relevance of the cutaneous microbiome in pediatric skin disease; systemic therapy for vascular malformations and the status of genotype-guided management; systemic therapy for pediatric atopic dermatitis; update on biologic therapy for pediatric psoriasis; hormonal treatment of acne in adolescent patients; and more.
-
Provides in-depth clinical reviews on pediatric dermatology, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Clinical Relevance of the Microbiome in Pediatric Skin Disease: A Review
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Systemic Therapy for Vascular Anomalies and the Emergence of Genotype-Guided Management
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Evolving Landscape of Systemic Therapy for Pediatric Atopic Dermatitis
- Key points
- Introduction
- Management
- Traditional systemic therapy
- Dupilumab
- Horizon
- Clinics care points
- Disclosures
- Clinical Decisions in Pediatric Psoriasis: A Practical Approach to Systemic Therapy
- Key points
- Introduction
- The systemic therapy tool box
- Assessment of severity
- Threshold for initiating systemic therapy
- Which drug for which pediatric patient?
- Additional considerations when selecting systemic therapies
- “Tried and true”
- Phototherapy
- Acitretin
- Methotrexate
- Cyclosporine
- “New and novel”
- TNFα inhibitors
- IL-12/23 inhibitor
- IL-17 inhibitors
- Targeted therapies in the pipeline
- Putting it all together: case 1 revisited
- Summary and discussion
- Hormonal Treatment of Acne and Hidradenitis Suppurativa in Adolescent Patients
- Key points
- Introduction/history/definitions/background
- Discussion
- The effects of other contraceptives on acne and hidradenitis suppurativa
- Summary
- Clinics care points
- Sweet Syndrome in the Pediatric Population
- Key points
- Introduction
- Background
- Initial evaluation
- Therapeutic options
- Ongoing management
- Tying it all together: an illustrative case report
- Discussion and future directions
- Summary
- Clinics care points
- Disclosure
- Morbilliform Eruptions in the Hospitalized Child
- Key points
- Morbilliform eruptions in the hospitalized child
- The history and definition of the morbilliform eruption
- Evaluation of the child with a morbilliform eruption
- Morbilliform eruptions in the unvaccinated child
- Morbilliform eruptions in the returning traveler
- Rickettsial diseases: rocky mountain spotted fever
- Morbilliform eruption in the COVID-19 era
- Morbilliform eruption with a recent drug history
- Morbilliform eruptions in a bone marrow transplant patient
- Acute graft-versus-host disease
- Engraftment syndrome
- Summary
- Clinics care points
- Disclosure
- Supportive Oncodermatology in Pediatric Patients
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Laser Surgery for Dermatologic Conditions in Pediatric Patients
- Key points
- Introduction
- Disease-specific laser treatment
- Refractory Port-Wine Birthmarks
- Hidradenitis Suppurativa
- Warts
- Clinics care points
- Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications
- Key points
- Introduction
- Terminology
- Methods
- Results
- Discussion
- Clinics care points
- Financial disclosure statement
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 40-2
- Published: April 6, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323897624
- eBook ISBN: 9780323897631
KC